MyoGene Bio participates in QB3 2020 Pitch Summit and receives in-kind service from Sartorius

November 18, 2020

MyoGene was selected as a finalist cohort member of QB3’s annual Pitch Summit, designed to facilitate connecting innovative life science companies to investors and partners. MyoGene received presentation coaching, pitched to investors and was selected to receive $25,000 of in-kind services from Sartorius. We appreciate their support!

Read more here: 

https://www.wfmz.com/news/pr_newswire/pr_newswire_health/qb3-congratulates-10-startups-selected-for-2020-pitch-summit-cohort/article_7409c226-86f2-5c0d-80c6-361632555e21.html 

and here: 

https://www.sartorius.com/en/knowledge/science-snippets/sartorius-awarded-myogene-bio-at-qb3-pitch-summit-630374?srsltid=AfmBOopgMssnqewpuNtYxuCFXuaC13_RtRCigUAQ19M85sF0DjnWF5Fu